Immune Exosome
FDA Cleared Ingredients
Ready to Use
First Liquid Exosome
19 Powerful
Active Agents
Fast Absorption
Special Formula
Immunity
Supporting
Ready-to-use sterile solution form, produced with DLC technology.
RICHESSE™ Collection
RICHESSE EXO19, containing high-purity immune exosomes obtained through advanced DLC (Dynamic Linker Cell) technology, offers a next-generation care solution in skin regeneration.
Its special formulation, developed with FDA-cleared ingredients, helps repair the skin barrier, maintain moisture balance, and support the cellular regeneration process. Thanks to its rapidly absorbed liquid structure, it provides maximum effect without leaving a feeling of heaviness after application.
| Packaging | 2.2 mL / Box |
|---|---|
| Core Ingredients | Hyaluronic Acid, Sodium DNA (PN), Peptides, Glutathione — Total 19 Active Ingredients |
| Application Areas | Face, Scalp, All areas needing regeneration |
| Technology | DLC (Dynamic Linker Cell) — TPC Progenitor Cell Technology |
| Exosome Size | Average 98.5 nm — High consistency and superior efficacy |
| Concentration | 3.3 × 10⁹ p/ml — Production capacity 100 times higher than competitors |
Individuals with thin corneal layer and poor skin regeneration
Those with large pores and excessive oiliness problems
Water-oil imbalance, dryness, and redness problems
Sensitive skin structure and seasonal allergies
Acne, pimples, and post-acne scars
Dull skin appearance and pigmentation problems
Inflamed skin or skin with compromised barrier integrity
Phase 01
Intensive Treatment
Once every 2 weeks
3 sessions
Phase 02
Strengthening
Once a month
2 sessions
Phase 03
Maintenance
Once every 3–6 months
1 session
Initial Phase: 5 sessions are recommended; at least 3 applications should be made for noticeable results.
Results: May vary individually; however, noticeable effects can appear within 2–3 days.
Skin Sensitivity: A new session should be performed after the complete skin healing process is finished.
This product is suitable for use by authorized healthcare professionals only. Contact our expert team for supply and pricing information.
Scientific Foundation
Exosomes isolated from progenitor cells of immune system origin are considered biological signal carriers that support intercellular communication. In skin applications, they aim to support tissue regeneration processes, strengthen the skin barrier, and contribute to increasing resistance against environmental factors.
3.3×10⁹
p/ml concentration
100 times higher production capacity compared to competitor products
98.5 nm
Average exosome size
Optimal sizing for high consistency and superior efficacy
19
Active ingredients
Comprehensive formula including HA, PN, Peptides, Glutathione, and more
TEXsome Exosomes, produced with EXO Progenitor Cells (TPC), are developed for the regulation and repair of the inflammatory immune system. Through TPC cells, high-concentration and perfectly sized exosomes are produced without the need for additional purification.
In-vitro cell migration (wound healing/scratch) tests have revealed that RICHESSE EXO-19 significantly increases cellular migration and the damaged area closes in a shorter time. It increases regenerative activity and accelerates the regeneration of tissue integrity.